Rafferty Asset Management, LLC
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 1389426
New York, NY
Position in VNDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$389,862
-$247,958 QoQ
Shares Held
63,703
-31.0% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 172 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. VNDA ranks #125 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in VNDA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $389,862 | 63,703 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $637,820 | 92,304 | Shares | Sole | 2026-05-15 | |
| 2023-06-30 | $1,450,439 | 220,097 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,562,283 | 230,086 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,035,634 | 140,140 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,355,200 | 137,166 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $924,810 | 84,845 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,948,961 | 172,322 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,042,790 | 130,197 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,399,292 | 81,639 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 ALXN | — | 39,187 | Shares | Sole | 2021-08-10 | |
| 2021-06-30 | $1,574,768 | 73,211 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 ALXN | — | 49,916 | Shares | Sole | 2021-05-10 | |
| 2021-03-31 | $1,520,039 | 101,201 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 ALXN | — | 35,301 | Shares | Sole | 2021-02-10 | |
| 2020-12-31 | $306,556 | 23,330 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 ALXN | — | 47,600 | Shares | Sole | 2020-11-13 | |
| 2020-09-30 | $631,706 | 65,394 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 ALXN | — | 37,722 | Shares | Sole | 2020-08-07 | |
| 2020-06-30 | $400,640 | 35,021 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 ALXN | — | 28,341 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||